Literature DB >> 23070479

The role of community pharmacists in the prevention and management of osteoporosis and the risk of falls: results of a cross-sectional study and qualitative interviews.

M-C Laliberté1, S Perreault, N Damestoy, L Lalonde.   

Abstract

UNLABELLED: In a mailed survey and qualitative interviews, it was observed that community pharmacists and public health authorities believe that pharmacists should play a significant role in the prevention and management of osteoporosis and the risk of falls. However, pharmacists acknowledge a wide gap between their ideal and actual levels of involvement.
INTRODUCTION: The aim of this study was to explore perceptions of community pharmacists and public health authorities regarding the role of pharmacists in providing services in relation to osteoporosis and risk of falls and the barriers to providing them.
METHODS: Using a modified five-step version of Dillman's tailored design method, a questionnaire was mailed to a random sample of 1,250 community pharmacists practicing in Montreal (Quebec, Canada) and surrounding areas. A similar questionnaire was sent to public health officers in these regions. Additionally, telephone interviews were conducted with regional and ministry level public health officers.
RESULTS: Of the 1,250 pharmacists contacted, 28 were ineligible. In all, 571 of 1,222 (46.7 %) eligible community pharmacists and all the public health officers returned the questionnaire. Six public health officers (five regional and one at ministry level) were interviewed. Most pharmacists believed they should be involved in screening for osteoporosis (46.6 %) and risk of falls (50.3 %); however, fewer reported actually being involved in such services (17.4 % and 19.2 %, respectively). In their view, the main barriers to providing these services in current practice were lack of time (78.8 %), lack of clinical tools (65.4 %), and lack of coordination with other healthcare professionals (54.5 %). Public health authorities also thought community pharmacists should play a significant role in providing osteoporosis and fall risk services. However, few community pharmacist-mediated activities are in place in the participating regions.
CONCLUSIONS: Although community pharmacists and public health authorities believe pharmacists should play a significant role with regard to osteoporosis and the risk of falls, they acknowledge a wide gap between the ideal and actual levels of pharmacist involvement.

Entities:  

Mesh:

Year:  2012        PMID: 23070479     DOI: 10.1007/s00198-012-2171-y

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  38 in total

1.  Community pharmacists' participation in health education and disease prevention activities.

Authors:  E C Paluck; T P Stratton; G O Eni
Journal:  Can J Public Health       Date:  1994 Nov-Dec

Review 2.  Coordinator-based systems for secondary prevention in fragility fracture patients.

Authors:  D Marsh; K Akesson; D E Beaton; E R Bogoch; S Boonen; M-L Brandi; A R McLellan; P J Mitchell; J E M Sale; D A Wahl
Journal:  Osteoporos Int       Date:  2011-05-24       Impact factor: 4.507

3.  Osteoporosis screening by community pharmacists: use of National Osteoporosis Foundation resources.

Authors:  Mary E Elliott; Patrick D Meek; Nathan L Kanous; Gary R Schill; Patricia A Weinswig; John P Bohlman; Casey L Zimpel; Brian C Jensen; Dan R Walters; Sue L Sutter; Andy N Peterson; Rhonda M Peterson; Neil C Binkley
Journal:  J Am Pharm Assoc (Wash)       Date:  2002 Jan-Feb

4.  A controlled trial to increase detection and treatment of osteoporosis in older patients with a wrist fracture.

Authors:  Sumit R Majumdar; Brian H Rowe; Deb Folk; Jeffrey A Johnson; Brian H Holroyd; Donald W Morrish; Walter P Maksymowych; Ivan P Steiner; Charles H Harley; Brian J Wirzba; David A Hanley; Sandra Blitz; Anthony S Russell
Journal:  Ann Intern Med       Date:  2004-09-07       Impact factor: 25.391

5.  Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial.

Authors:  N Yuksel; S R Majumdar; C Biggs; R T Tsuyuki
Journal:  Osteoporos Int       Date:  2009-06-05       Impact factor: 4.507

6.  Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from Project ImPACT: Osteoporosis.

Authors:  Jean-Venable Goode; Kim Swiger; Benjamin M Bluml
Journal:  J Am Pharm Assoc (2003)       Date:  2004 Mar-Apr

Review 7.  Improving quality of care in osteoporosis: opportunities and challenges.

Authors:  Gim Gee Teng; Amy Warriner; Jeffrey R Curtis; Kenneth G Saag
Journal:  Curr Rheumatol Rep       Date:  2008-04       Impact factor: 4.592

8.  Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trial.

Authors:  Adrianne Feldstein; Patricia J Elmer; David H Smith; Michael Herson; Eric Orwoll; Chuhe Chen; Mikel Aickin; Martha C Swain
Journal:  J Am Geriatr Soc       Date:  2006-03       Impact factor: 5.562

9.  Ideal and actual involvement of community pharmacists in health promotion and prevention: a cross-sectional study in Quebec, Canada.

Authors:  Marie-Claude Laliberté; Sylvie Perreault; Nicole Damestoy; Lyne Lalonde
Journal:  BMC Public Health       Date:  2012-03-15       Impact factor: 3.295

10.  Improving care of patients at-risk for osteoporosis: a randomized controlled trial.

Authors:  Daniel H Solomon; Jennifer M Polinski; Margaret Stedman; Colleen Truppo; Laura Breiner; Catherine Egan; Saira Jan; Minal Patel; Thomas W Weiss; Ya-ting Chen; M Alan Brookhart
Journal:  J Gen Intern Med       Date:  2007-03       Impact factor: 5.128

View more
  3 in total

1.  Perspectives of primary care providers on multidisciplinary collaboration to prevent medication-related falls.

Authors:  Marle Gemmeke; Katja Taxis; Marcel L Bouvy; Ellen S Koster
Journal:  Explor Res Clin Soc Pharm       Date:  2022-06-09

2.  Improving osteoporosis management in general practice: a pharmacist-led drug use evaluation program.

Authors:  Edwin C K Tan; Johnson George; Kay Stewart; Rohan A Elliott
Journal:  Drugs Aging       Date:  2014-09       Impact factor: 3.923

3.  A qualitative study of community pharmacists' opinions on the provision of osteoporosis disease state management services in Malaysia.

Authors:  Jah Nik; Pauline Siew Mei Lai; Chirk Jenn Ng; Lynne Emmerton
Journal:  BMC Health Serv Res       Date:  2016-08-30       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.